Please login to the form below

Not currently logged in
Email:
Password:

Pharmalink

This page shows the latest Pharmalink news and features for those working in and with pharma, biotech and healthcare.

Pharmalink appoints new chairman Anders Wiklund

Pharmalink appoints new chairman Anders Wiklund. The Swedish specialty pharma company has also appointed Elisabeth Lindner to its board of directors. ... Anders Wiklund has joined Swedish specialty pharma company Pharmalink AB as chairman of the board.

Latest news

  • News in brief, July 04, 2007

    Eli Lilly divests Distaclor antibiotic. The Indian subsidiary of global pharmaceutical major Eli Lilly has divested its antibiotic Distaclor (cefaclor) to Pharmalink, a subsidiary of Quintiles International, for an undisclosed sum,

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • ReNeuron appoints new CEO ReNeuron appoints new CEO

    Hellebø, who has also previously held directorship positions at Pharmalink and Palma Biotech, said ReNeuron impressed him with their technology, team and strong investment backing.

  • Pharmalink appoints Dr Heather Cook and Marek Poszepczynski Pharmalink appoints Dr Heather Cook and Marek Poszepczynski

    Pharmalink has bolstered its senior management team with the appointment of Dr Heather Cook and Marek Poszepcynski (pictured). ... Pharmalink's other senior management appointment is Marek Poszepcynski who takes up the role of director of business

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is the UK arm of Zeno Group, a global integrated communications consultancy. Everything we do is rooted...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics